Latest Articles
Baylen Dupree-Dooley is diagnosed endometriosis in the Season 3 finale of "Baylen Out Loud," airing Tuesday, Aug. 4, 2026. - The Daily News | Texas' Oldest Newspaper
Baylen Dupree-Dooley is diagnosed endometriosis in the Season 3 finale of "Baylen Out Loud," airing Tuesday, Aug. 4, 2026. The Daily News | Texas' Oldest Newspaper
Published: Aug. 4, 2026, 2 p.m.
Baylen Dupree-Dooley is diagnosed endometriosis in the Season 3 finale of "Baylen Out Loud," airing Tuesday, Aug. 4, 2026. - galvnews.com
Baylen Dupree-Dooley is diagnosed endometriosis in the Season 3 finale of "Baylen Out Loud," airing Tuesday, Aug. 4, 2026. galvnews.com
Published: Aug. 4, 2026, 2 p.m.
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive - azcentral.com
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive azcentral.com
Published: Aug. 4, 2026, 1:38 p.m.
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive - azcentral.com and The Arizona Republic
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive azcentral.com and The Arizona Republic
Published: Aug. 4, 2026, 1:38 p.m.
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval - Corsicana Daily Sun
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Corsicana Daily Sun
Published: Aug. 4, 2026, 1:02 p.m.
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval - Voice of Alexandria
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Voice of Alexandria
Published: Aug. 4, 2026, 1:02 p.m.
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive - USA Today
'Baylen Out Loud' star Baylen Dupree reveals endometriosis diagnosis | Exclusive USA Today
Published: Aug. 4, 2026, 1:01 p.m.
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval Stock Titan
Published: Aug. 4, 2026, 1 p.m.
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Benzinga
Published: Aug. 4, 2026, 12:31 p.m.
Diffuse Adenomyosis Coexisting with rASRM Stage IV Endometriosis in a | IJWH - Dove Medical Press
Diffuse Adenomyosis Coexisting with rASRM Stage IV Endometriosis in a | IJWH Dove Medical Press
Published: Aug. 4, 2026, 9:23 a.m.
Link copied to clipboard!